|
|
Volumn 41, Issue 2, 2013, Pages 197-199
|
|
Difficult-to-treat Gram-negative bone and joint infections: Efficacy and safety of prolonged intravenous colistin
a,b,i
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COLISTIN;
ACUTE KIDNEY FAILURE;
ADULT;
BACTERIAL STRAIN;
BACTERIUM IDENTIFICATION;
BONE INFECTION;
CHRONIC DRUG ADMINISTRATION;
CLINICAL ARTICLE;
CLINICAL EFFECTIVENESS;
CONTINUOUS INFUSION;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DISEASE ASSOCIATION;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSESTHESIA;
ENTEROBACTER AEROGENES;
EOSINOPHIL COUNT;
FEMALE;
HUMAN;
INFECTIOUS ARTHRITIS;
LETTER;
LOW DRUG DOSE;
MALE;
OSTEOMYELITIS;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
RISK FACTOR;
SIDE EFFECT;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
COHORT STUDIES;
COLISTIN;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
DRUG TOXICITY;
FEMALE;
FRANCE;
GRAM-NEGATIVE BACTERIA;
GRAM-NEGATIVE BACTERIAL INFECTIONS;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
OSTEOARTHRITIS;
RETROSPECTIVE STUDIES;
SWITZERLAND;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 84872345410
PISSN: 09248579
EISSN: 18727913
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2012.09.016 Document Type: Letter |
|
Times cited : (14)
|
|
References (5)
|
